TITLE

Effects of topical timolol (0.5%) and betaxolol (0.5%) on corneal sensitivity

AUTHOR(S)
Weissman, S S; Asbell, P A
PUB. DATE
July 1990
SOURCE
British Journal of Ophthalmology;Jul1990, Vol. 74 Issue 7, p409
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66062980

 

Related Articles

  • Beta blockers alter circulation. Steefel, Lorraine // Ophthalmology Times;8/15/96, Vol. 21 Issue 22, p28 

    Reports on the findings of several research on the effects of beta blockers on ocular circulation. Ability of levobunolol to increase retinal blood; Effect of timolol and betaxolol on choroidal blood flow; Effectiveness of betaxolol in preserving vision in patients with decreased IOP.

  • Ocular and Retrobulbar Blood Flow in Ocular Hypertensives Treated with Topical Timolol, Betaxolol and Carteolol. Steigerwalt Jr, Robert D.; Laurora, Giuseppe; Belcaro, Gianni V.; Cesarone, Maria R.; De Sanctis, Maria T.; Incandela, Lucrezia; Minicucci, Renato // Journal of Ocular Pharmacology & Therapeutics;Dec2001, Vol. 17 Issue 6, p537 

    The purpose of this study was to evaluate the effect of topical timolol 0.5%, betaxolol 0.5% and carteolol 2% on the blood flow velocity of the central retinal artery (CRA), the posterior ciliary artery (PCA) and the ophthalmic artery (OA) in patients with ocular hypertension. A group of 14...

  • The Effects on the Intraocular Pressure and Visual Field Resulting from a Switch in the Treatment from Timolol to Betaxolol. Miki, Hirohiko; Miki, Katsuaki // Journal of Ocular Pharmacology & Therapeutics;Dec2004, Vol. 20 Issue 6, p509 

    Patients with primary open-angle glaucoma (POAG) were dosed twice-daily with 0.5% timolol maleate for 2 years, followed by 2 years of twice-daily dosing with 0.5% betaxolol hydrochloride. The changes in intraocular pressure (IOP) and effects on visual field by each treatment were monitored over...

  • Effect of Topical Betaxolol on Tissue Circulation in the Human Optic Nerve Head. Tamaki, Yasuhiro; Araie, Makoto; Tomita, Ken; Nagahara, Miyuki // Journal of Ocular Pharmacology & Therapeutics;Aug99, Vol. 15 Issue 4, p313 

    Examines the effect of topical betaxolol on tissue blood velocity in the human optic nerve head (ONH). Risk factor for glaucomatous damage to ONH; Information on betaxolol; Factor that may increase blood velocity and normalized blur.

  • Betaxolol presents neuroprotective effect in animals. Edelson, Ed; Osborne, Neville // Ophthalmology Times;04/01/2001, Vol. 26 Issue 7, p74 

    Focuses on the neuroprotective effects of topical drug betaxolol in animals. Results of studies done on the eyes of rats, rabbits and monkeys.

  • Ophthalmic Preservatives: Considerations for Long-term Use in Patients With Dry Eye or Glaucoma. Noecker, Robert // Review of Ophthalmology;Jun2001 Part 1 of 2, Vol. 8 Issue 6, p73 

    Examines the effects of continuous opthalmic medications on patients with glaucoma. Cytotoxicity of opthalmic preservatives on human corneal epithelium; Adverse effects of topical anti-glaucoma medication; Comparison between the effects of preserved and unpreserved formulations of timolol on...

  • Differences in spirometry using topical timolol carteolol or betaxolol. Diggory, P.; Cassels-Brown, A. // Age & Ageing;Sep96 Supplement, Vol. 25, p23 

    Presents an abstract of the study `Differences in Spirometry Using Topical Timolol Carteolol or Betaxolol,' by P. Diggory, A. Cassels-Brown and C. Fernandez, presented during the Communications to the Spring Meeting of the British Geriatrics Society on April 11-13, 1996 in Canterbury, England.

  • Ocular Carteolol: A Review of its Use in the Management of Glaucoma and Ocular Hypertension. Henness, Sheridan; Harrison, Tracy Swainston; Keating, Gillian M. // Drugs & Aging;2007, Vol. 24 Issue 6, p509 

    Ocular carteolol (Mikelan®, Teoptic®, Ocupress®) is a nonselective β-adrenoceptor antagonist with intrinsic sympathomimetic activity (ISA). Ocular carteolol effectively reduces intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OH)....

  • Assessment of Systemic Adverse Reactions Induced by Ophthalmic �-Adrenergic Receptor Antagonists. Yamada, Yasuhiko; Takayanagi, Risa; Tsuchiya, Kohtarou; Ito, Kiyomi; Ohtani, Hisakazu; Sawada, Yasufumi; Iga, Tatsuji // Journal of Ocular Pharmacology & Therapeutics;Jun2001, Vol. 17 Issue 3, p235 

    To assess quantitatively the risks of ophthalmic beta-blocking agents for cardiovascular and respiratory adverse reactions, we analyzed the binding kinetics of beta-blocking agents to the beta-1 and beta-2 adrenoceptors. The relationship between the occupancies for beta-1 and beta-2...

  • INHIBITORY EFFECTS OF TIMOLOL MALEATE AND ITS PRESERVATIVE BENZALKONIUM CHLORIDE ON CORNEAL EPITHELIAL MIGRATION IN A RABBIT ORGAN CULTURE SYSTEM. Mushtaq, Shamin; Siddiqui, Anwar Ali; Ahmed, Nikhat // IIOAB Journal;Jan/Feb2012, Vol. 3 Issue 1, p15 

    Purpose: Timolol maleate, the ophthalmic solutions, is frequently prescribed for glaucoma, although the use of this drop is likely to interfere with wound healing in corneal surgeries. A possible factor that may influence rates of corneal wound healing is how the solutions are preserved. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics